TidalSense
Cambridge
About TidalSense
Developer of AI-driven respiratory diagnostic and monitoring technologies. The company's technologies are built on a foundation of a novel sensor technology (N-Tidal) that is able to detect changes in lung function quickly and accurately. N-Tidal converts sensor data into (novel) respiratory biomarkers in near-real-time (minutes). Data is managed automatically and the device is 4G connected, handheld, portable and has high patient acceptability. Using these biomarkers, the company has built an affordable AI-driven diagnostic test for COPD which automates testing and interpretation in under 5 minutes (compared to the clinical standard 30 minutes).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.6M
- Funding stage: Seed
- Last round: Seed (May 2023)
- Website: tidalsense.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/tidalsense-67272 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.